DUBLIN--(BUSINESS WIRE)--The "Transcutaneous Bilirubinometers Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The Transcutaneous Bilirubinometers Market is expected to register a CAGR of 6% during the forecast period.
Transcutaneous bilirubinometers are widely used for noninvasive transcutaneous bilirubin with hyperbilirubinemia. The market is growing at a good rate attributing to rising incidence of jaundice in neonatal patients and technological advancements in the transcutaneous bilirubinometers. As per National Institute of Health (NIH) in 2019, neonatal hyperbilirubinemia was a leading cause of hospitalization, an estimate of 60-80% of newborn babies were affected by this condition which further results in driving the transcutaneous bilirubinometers for screening infants.
Moreover, technological advancement coupled with increasing demand of noninvasive and reliable techniques for the measurement of serum bilirubin is also likely to propel the market to certain extent. However, high cost of bilirubin meters and shortage of skilled workforce may hamper the market.
- Drgerwerk AG & Co. KGaA
- Xuzhou Kejian Hi-tech Co. ltd.
- Mennen Medical Ltd. ( Nektop Ltd.)
- Koninklijke Philips N.V.
- Micro Lab Instruments
- Zhengzhou Dison Instrument And Meter Co., Ltd
- GINEVRI srl
Key Market Trends
Portable Transcutaneous Billirubinometers is Expected to Witness a Healthy Growth in Future
Portable transcutaneous billirubinometers are expected to witness a healthy growth in future attributing to its flexibility, ease of use, non- invasive, increased mobility. As technological advancements in the transcutaneous billirubinometers resulting in high adoptions in diagnostic laboratories and hospitals for screening purposes. This high demand of portable transcutaneous billirubinometers results in promoting the segment growth.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Transcutaneous Bilirubinometers Market due to increasing incidence of jaundice in neonatal patients, increasing healthcare expenditure and presence of well-established healthcare infrastructure. As per Global Health Data Exchange, in 2017 number of prevalence rate in United States for hemolytic diseases and neonatal jaundice are increased (27,736) from earlier years, resulting in adoption of transcutaneous bilirubinometers for screening and diagnosis. This adoption of bilirubinometers leading to drive the market in this region.
Key Topics Covered:
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Jaundice in Neonatal Patients
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Bilirubin Meters and Shortage of Skilled Workforce
4.4 Porter's Five Force Analysis
5 MARKET SEGMENTATION
5.1 By Type
5.2 By End User
5.2.2 Research Laboratories
5.3.1 North America
5.3.4 Middle-East and Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/eka0f0